First humans dosed in early trial for future blood clot drug
NCT ID NCT06665828
Summary
This was the first study to give a new experimental drug called REGN9533 to people. The main goal was to check if the drug is safe and to find a good dose in 72 healthy volunteers. This early research is a necessary first step before testing the drug in people who have blood clotting diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Belgium NV_Edegem
Edegem, Antwerp, 2650, Belgium
Conditions
Explore the condition pages connected to this study.